Although no differences were seen on ex vivo Th memory cells from patients and controls, CCR6 expression levels were reduced in vitro after the addition of third trimester compared to postpartum MS-NR sera (Figure 2D; p < 0.001). This evidence concerns the gene CCR6 and myeloid sarcoma.